Does TB-500 speed injury recovery?
TB-500 is promoted online as a peptide that speeds soft-tissue recovery.
Verdict: Unproven
Certainty: Very Low
Claim type: Peptide
Last checked: Jun 27, 2026
Evidence grade: Mechanism Only
Human review: Required before production publication
Direct answer
TB-500 injury-recovery claims are not supported by strong human clinical evidence. The claim often relies on extrapolation from thymosin beta-4 biology and should be treated as unproven.
Why people are asking
The claim travels through recovery and performance communities where people are looking for faster injury timelines.
What the evidence shows
- Mechanistic interest does not establish consumer recovery benefit.
- Human evidence for broad injury recovery is not strong enough for a positive verdict.
- FDA compounding review language is use-specific and not the same as consumer approval.
Strongest evidence
Checks whether human recovery evidence exists for the actual claim.
- Publisher
- PubMed
- Accessed
- Jun 27, 2026
- Study type
- Other
Limitations: A search result is a source-discovery card, not a single definitive study.
FDA listed TB-500 for wound healing review, not broad recovery approval.
- Publisher
- FDA
- Accessed
- Jun 27, 2026
- Study type
- Regulatory Document
Limitations: Regulatory status is use-specific and can change; readers should verify current labels and official notices.
Weakest link in the claim
- The weak link is translating mechanism into unsupervised injury-recovery claims.
What this does not prove
- It does not prove faster recovery in healthy adults.
- It does not prove internet products match studied material.
- It does not establish approval for recovery, anti-aging or performance uses.
What would change our mind
- Controlled human trials in defined injury populations.
- Transparent product identity and regulatory clarity.
- Replication by independent groups.
Money trail
Clinic Or TelehealthCommercial context does not automatically make a claim false, but it changes how carefully the claim should be read.
- TB-500 is often sold through recovery-oriented offers, which raises commercial-context questions.
What not to do
- Do not self-administer based on this page.
- Do not use this page for dosing, sourcing, stacking, cycle planning or injection instructions.
- Do not start, stop or combine drugs, peptides, supplements or experimental interventions without a qualified clinician.
Questions to ask a qualified clinician
- What exact medical indication is being discussed, and is it approved for that use?
- What human evidence exists for my situation, not just animals, cells or biomarkers?
- What monitoring, contraindications and interaction questions matter before any decision?
- What outcome would show benefit, and what outcome would show harm or no effect?
Practical takeaway
TB-500 remains an unproven and high-risk claim category for injury recovery.
FAQs
Does this page give a protocol?
No. LHN claim checks explain evidence, risk, regulatory status and source context. They do not provide personal medical instructions.
Is TB-500 the same as thymosin beta-4?
Not exactly. Claims often blur related biology with product-specific evidence.
Related claims
Does BPC-157 heal tendon and ligament injuries in humans?
No strong human evidence shows that BPC-157 heals tendon or ligament injuries. Most support is animal, cell or mechanism-based, and internet recovery claims should not be treated as proven clinical benefit.
Does MOTS-c improve metabolism and longevity?
MOTS-c is biologically interesting, but human metabolism and longevity claims remain unproven. Do not treat mitochondrial mechanism as clinical proof.
Related articles
What is TB-500 and how is it different from thymosin beta-4?
TB-500 is usually marketed as a peptide fragment related to thymosin beta-4, but naming can blur important evidence and quality questions.